Skip to Main Content

Paper Details

A Transcriptome-Based Precision Oncology Platform for Patient-Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies.
Cancer Discov
11
2023
MR, MR modules, Patient, Treatment-Resistant Malignancies, cancer, cognate cell lines, low, master regulator (MR) proteins, patient, patients, poor-prognosis malignancies, transcriptome, tumor
Author NameAffiliation
Katherine D CrewHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center
Katherine D CrewColumbia University Irving Medical Center
Katherine D CrewHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center
Katherine D CrewColumbia University Irving Medical Center
Dawn L HershmanHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center
Dawn L HershmanColumbia University Mailman School of Public Health
Dawn L HershmanColumbia University Irving Medical Center
Guy M McKhannHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center
Guy M McKhannColumbia University Irving Medical Center
Alfred I NeugutHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center
Alfred I NeugutColumbia University Mailman School of Public Health
Alfred I NeugutColumbia University Irving Medical Center
Hanina HibshooshHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center
Hanina HibshooshColumbia University Irving Medical Center
Mariano J AlvarezColumbia University Irving Medical Center
Mariano J AlvarezDarwinHealth Inc.
Andrea CalifanoColumbia University Irving Medical Center
Andrea CalifanoHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center
Andrea CalifanoColumbia University Irving Medical Center
Andrea CalifanoColumbia University Irving Medical Center
Andrea CalifanoColumbia University Irving Medical Center
Andrea CalifanoColumbia University Irving Medical Center
  • 1 - 22

Datasets

Release 1.2